Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Barriers and facilitators of a large clinical trial on prevention of HIV transmission through breastfeeding in Lusaka, Zambia: a qualitative study.
Mennecier A, Matoka B, Wilfred-Tonga MM, Chunda-Liyoka C, Mwiya M, Nagot N, Molès JP, Van de Perre P, Kankasa C, King R; PROMISE-EPI social science sub-study group. Mennecier A, et al. Among authors: kankasa c. BMC Public Health. 2024 Dec 2;24(1):3356. doi: 10.1186/s12889-024-20855-5. BMC Public Health. 2024. PMID: 39623353 Free PMC article.
Combination of serological and cytokine release assays for improved diagnosis of childhood tuberculosis in Zambia (PROMISE-TB).
Tuaillon E, Mwyia M, Bollore K, Pisoni A, Rubbo PA, Richard M, Kremer L, Tonga MMW, Chanda D, Peries M, Vallo R, Eymard-Duvernay S, D'Ottavi M, Kankasa C, de Perre PV, Moles JP, Nagot N. Tuaillon E, et al. Among authors: kankasa c. Int J Infect Dis. 2024 Nov;148:107248. doi: 10.1016/j.ijid.2024.107248. Epub 2024 Sep 26. Int J Infect Dis. 2024. PMID: 39341421 Free article.
Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
Kankasa C, Mennecier A, Sakana BLD, Molès JP, Mwiya M, Chunda-Liyoka C, D'Ottavi M, Tassembedo S, Wilfred-Tonga MM, Fao P, Rutagwera D, Matoka B, Kania D, Taofiki OA, Tylleskär T, Van de Perre P, Nagot N; PROMISE-EPI Trial Group. Kankasa C, et al. Lancet. 2024 Apr 6;403(10434):1362-1371. doi: 10.1016/S0140-6736(23)02464-9. Epub 2024 Mar 11. Lancet. 2024. PMID: 38484756 Clinical Trial.
Evaluation of the prevention of mother-to-child transmission of HIV programs at the second immunization visit in Burkina Faso and Zambia.
Tassembedo S, Mwiya M, Mennecier A, Kankasa C, Fao P, Molès JP, Kania D, Chunda-Liyoka C, Sakana BLD, D'Ottavi M, Taofiki AO, Rutagwera D, Wilfred-Tonga MM, Tylleskär T, Nagot N, Van de Perre P; PROMISE-EPI Study Group. Tassembedo S, et al. Among authors: kankasa c. AIDS. 2024 May 1;38(6):875-885. doi: 10.1097/QAD.0000000000003827. Epub 2024 Jan 4. AIDS. 2024. PMID: 38181091 Free PMC article.
Facilitators and barriers to infant post-natal HIV prophylaxis, a qualitative sub-study of the PROMISE-EPI trial in Lusaka, Zambia.
Mennecier A, Matoka B, Wilfred-Tonga MM, Chunda-Liyoka C, Mwiya M, Nagot N, Molès JP, Van de Perre P, Kankasa C, King R; PROMISE-EPI social science sub-study group. Mennecier A, et al. Among authors: kankasa c. Front Public Health. 2023 Aug 17;11:1242904. doi: 10.3389/fpubh.2023.1242904. eCollection 2023. Front Public Health. 2023. PMID: 37663847 Free PMC article. Clinical Trial.
Long-Term Persistence of Mitochondrial DNA Instability in HIV-Exposed Uninfected Children during and after Exposure to Antiretroviral Drugs and HIV.
Desquiret-Dumas V, D'Ottavi M, Monnin A, Goudenège D, Méda N, Vizeneux A, Kankasa C, Tylleskar T, Bris C, Procaccio V, Nagot N, Van de Perre P, Reynier P, Molès JP. Desquiret-Dumas V, et al. Among authors: kankasa c. Biomedicines. 2022 Jul 25;10(8):1786. doi: 10.3390/biomedicines10081786. Biomedicines. 2022. PMID: 35892686 Free PMC article.
159 results